amitriptyline has been researched along with kainic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
Cai, Z; McCaslin, PP | 1 |
Ho, IK; McCaslin, PP; Smith, TG; Yu, XZ | 1 |
3 other study(ies) available for amitriptyline and kainic acid
Article | Year |
---|---|
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture.
Topics: Amitriptyline; Animals; Calcium; Calcium Channel Blockers; Carbamazepine; Cells, Cultured; Cerebellum; Cyproheptadine; Desipramine; Kainic Acid; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 1992 |
Amitriptyline prevents N-methyl-D-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate.
Topics: Amitriptyline; Animals; Cell Death; Cells, Cultured; Extracellular Matrix; Glutamates; Imipramine; Kainic Acid; Lethal Dose 50; N-Methylaspartate; Neurons; Nortriptyline; Quisqualic Acid; Rats; Rats, Inbred Strains; Taurine | 1992 |